Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-CD8 alpha Antibody-APC (6L958)
😃Good
Catalog No. TMAY-01409A
Alias p32 186910, p32, MAL, Leu-2, Leu2, CD8a molecule, CD8 α, CD8 alpha, CD8
Anti-CD8 alpha Antibody-APC (6L958) is a APC-conjugated Mouse antibody targeting CD8 alpha. Anti-CD8 alpha Antibody-APC (6L958) can be used in FCM.
Anti-CD8 alpha Antibody-APC (6L958)
Anti-CD8 alpha Antibody-APC (6L958)
😃Good
Catalog No. TMAY-01409AAlias p32 186910, p32, MAL, Leu-2, Leu2, CD8a molecule, CD8 α, CD8 alpha, CD8
Anti-CD8 alpha Antibody-APC (6L958) is a APC-conjugated Mouse antibody targeting CD8 alpha. Anti-CD8 alpha Antibody-APC (6L958) can be used in FCM.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 T | $33 | 7-10 days | |
| 100 T | $105 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Antibody Type: Mouse Monoclonal Application: FCM Reactivity: Human |
| Alias | p32 186910, p32, MAL, Leu-2, Leu2, CD8a molecule, CD8 α, CD8 alpha, CD8 |
| Ig Type | Mouse IgG2b |
| Clone | 6L958 |
| Reactivity | Human |
| Verified Activity | Flow cytometric analysis of Human CD8a expression on human whole blood lymphocytes. Cells were stained with APC-conjugated anti-Human CD8a. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. |
| Application | FCM |
| Recommended Dose | 2 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD8 alpha/CD8A (rh CD8 alpha/CD8A; NP_001759.3Met1-Asp182) and conjugated with APC under optimum conditions, the unreacted APC was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
| Research Background | T-cell surface glycoprotein CD8 alpha chain, also known as CD8a, is a single-pass type I membrane protein. The CD8 glycoprotein is expressed by thymocytes, mature T cells and natural killer (NK) cells and has been implicated in the recognition of monomorphic determinants on major histocompatibility complex (MHC) Class I antigens, and in signal transduction during the course of T-cell activation. Both human and rodent CD8 antigens are comprised of two distinct polypeptide chains, alpha and beta. The Ig domains of CD8 alpha are involved in controlling the ability of CD8 to be expressed. Mutation of B- and F-strand cysteine residues in CD8 alpha reduced the ability of the protein to fold properly and, therefore, to be expressed. Defects in CD8A are a cause of familial CD8 deficiency. Familial CD8 deficiency is a novel autosomal recessive immunologic defect characterized by absence of CD8+ cells, leading to recurrent bacterial infections. |
| Conjucates | APC |
| Others Formats | Unconjugated/PerCP/FITC/PE |
| Antibody Types Available | 5 |
| Immunogen | Recombinant Protein: Human CD8 alpha/CD8A Protein |
| Antigen Species | Human |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-CD8 alpha Antibody-APC (6L958) | purchase Anti-CD8 alpha Antibody-APC (6L958) | Anti-CD8 alpha Antibody-APC (6L958) cost | order Anti-CD8 alpha Antibody-APC (6L958)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.